WRN and Werner syndrome: In line with this, NAD+ augmentation, via supplementation with nicotinamide riboside, reduced senescence and improved mitochondrial metabolic profiles in mesenchymal stem cells with WRN knockout (WRN−/−) and in primary fibroblasts derived from WS patients compared to controls.